menu
    • menu

    Company profile for Azurity Pharma

    NEW Drugs in Dev: 7
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We focus on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist. Azurity’s growing portfolio of FDA-approved drugs eliminates the need for compounding and gives these patients an easy-to-consume medication that meets the highest standards of safety and efficacy.In some cases, when an FDA-approved formulation ...
    We focus on the needs of special patient populations, such as children and the elderly, for whom customized doses and user-friendly formulations tailored to their needs do not exist. Azurity’s growing portfolio of FDA-approved drugs eliminates the need for compounding and gives these patients an easy-to-consume medication that meets the highest standards of safety and efficacy.In some cases, when an FDA-approved formulation is not yet available and compounding is required, our convenient FIRST® Unit-of-Use Kits allow pharmacists to provide patients with a product manufactured with high quality and standardization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Azurity PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8 Cabot Road, Suite 2000, Woburn, MA 01801
    Telephone
    Telephone
    1-800-461-7449
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://azurity.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/azuritypharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/azuritypharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    QHP Launches $1.1B Fund For Azurity Pharmaceuticals
    QHP Launches $1.1B Fund For Azurity Pharmaceuticals

    18 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-18/qhp-announces-11-billion-continuation-vehicle-for-azurity-pharmaceuticals

    PHARMIWEB
    18 Mar 2026
    Share Share
    Azurity’s Resniben Receives Tentative Approval in US
    Azurity’s Resniben Receives Tentative Approval in US

    24 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220258

    FDA
    24 Oct 2025
    Share Share
    Azurity’s Javadin Receives Approval in US
    Azurity’s Javadin Receives Approval in US

    23 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220256

    FDA
    23 Oct 2025
    Share Share
    George Medicines, Biolab Sign Deal for GMRx2 Commercialization
    George Medicines, Biolab Sign Deal for GMRx2 Commercialization

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160235/0/en/George-Medicines-strengthens-global-commercialization-strategy-for-GMRx2-with-exclusive-Biolab-Farmac%C3%AAutica-licensing-agreement-in-Brazil.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share
    Azurity Pharma Launches BRYNOVIN™, First Oral Liquid Sitagliptin
    Azurity Pharma Launches BRYNOVIN™, First Oral Liquid Sitagliptin

    31 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-the-availability-of-brynovin-sitagliptin-the-first-and-only-oral-liquid-sitagliptin-302519017.html

    PR NEWSWIRE
    31 Jul 2025
    Share Share
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118577/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Azurity-Pharmaceuticals-to-commercialize-WIDAPLIK-telmisartan-amlodipine-and-indapamide-tablets-in-the-US.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Azurity Pharma and get a quotation

    Azurity Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Glucagon bulk offered by Azurity Pharma

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search